Claims for Patent: 7,105,654

Summary for Patent: 7,105,654

Title:	Ethylene receptor gene from Glycine max and its use
Abstract:	The present invention relates to an isolated nucleic acid sequence from a soybean plant (Glycine max) encoding an ethylene receptor polypeptide. The present invention also relates to methods for reducing an ethylene-induced abscission of reproductive structures by producing a transformed plant containing a modified ethylene receptor gene. The transformed plants herein produced demonstrate yield enhancement at their maturity.
Inventor(s):	Nelson; Donald E. (Stonington, CT)
Assignee:	Monsanto Technology LLC (St. Louis, MO)
Application Number:	10/325,034
Patent Claims:	1. An isolated nucleic acid molecule, comprising a soybean nucleotide sequence encoding an ethylene receptor protein having an amino acid sequence that is at least 95% identical over the full length of SEQ ID NO: 6, wherein the amino acid at position 66 is tyrosine. 2. The isolated nucleic acid molecule of claim 1, comprising the nucleotide sequence as set forth in SEQ ID NO: 5 or the complement thereof. 3. A recombinant DNA construct, comprising a structural nucleotide sequence encoding an ethylene receptor protein having an amino acid sequence that is at least 95% identical over the full length of SEQ ID NO: 6, wherein the amino acid at position 66 is tyrosine, said structural nucleotide sequence being operably linked upstream at the 5' end to a promoter and downstream at the 3' end to a regulatory element. 4. The recombinant DNA construct of claim 3, wherein the promoter is selected from the group consisting of a MADS domain transcription factor, cellulase, polygalacturonase, nopaline synthase (NOS), octopine synthase (OCS), mannopine synthase (mas), cauliflower mosaic virus 19S and 35S (CaMV19S, CaMV35S), enhanced CaMV (eCaMV), ribulose 1,5-bisphosphate carboxylase (ssRUBISCO), figwort mosaic virus (FMV), CaMV derived AS4, tobacco RB7, wheat POX1, tobacco EIF-4, lectin protein (Lel), and rice RC2 promoter. 5. The recombinant DNA construct of claim 3, wherein said regulatory element comprises an intron. 6. The recombinant DNA construct of claim 5, wherein said intron comprises a hsp70 intron. 7. A recombinant host cell, comprising the recombinant DNA construct of any one of claims 3 6. 8. The recombinant host cell of claim 7 which is a transgenic plant cell. 9. A transgenic plant, comprising the transgenic plant cell of claim 8. 10. A method for preparing a transgenic plant, comprising: (a) selecting a host plant cell; (b) transforming the host plant cell with a recombinant construct comprising a structural nucleotide sequence; (c) obtaining a transformed plant cell; and (d) regenerating a transgenic plant from the transformed plant cell, wherein the structural nucleotide sequence is a nucleic acid sequence encoding an ethylene receptor protein having an amino acid sequence that is at least 95% identical over the full length of SEQ ID NO: 6, wherein the amino acid at position 66 is tyrosine; and wherein said transgenic plant demonstrates reduced abscission of reproductive structures relative to a non-transgenic plant of the same species. 11. The method of claim 10, wherein the transgenic plant is an apple, apricot, pear, plum, blackberry, blueberry, strawberry, cranberry, lemon, maize, wheat, rye, barley, oat, buckwheat, sorghum, rice, sunflower, canola, pea, bean, soybean, cotton, linseed, cauliflower, asparagus, lettuce, tobacco, mustard, sugarbeet, potato, sweet potato, carrot, turnip, celery, tomato, eggplant, cucumber or squash plant. 12. The transgenic plant of claim 9, wherein the transgenic plant is an apple, apricot, pear, plum, blackberry, blueberry, strawberry, cranberry, lemon, maize, wheat, rye, barley, oat, buckwheat, sorghum, rice, sunflower, canola, pea, bean, soybean, cotton, linseed, cauliflower, asparagus, lettuce, tobacco, mustard, sugarbeet, potato, sweet potato, carrot, turnip, celery, tomato, eggplant, cucumber or squash plant. 13. Progeny of the transgenic plant of claim 12 comprising a recombinant DNA construct with a structural nucleotide sequence encoding an ethylene receptor protein having an amino acid sequence that is at least 95% identical over the full length of SEQ ID NO: 6, wherein the amino acid at position 66 is tyrosine.

Details for Patent 7,105,654

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2022-01-02
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2022-01-02
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2022-01-02